Top

Published in:

01-09-2019 | Retinoblastoma | Case report

Antineoplastics

Various toxicities: 3 case reports

Published in: Reactions Weekly | Issue 1/2019

Excerpt

In a single-centre, retrospective study of 39 patients (aged 0.3−3 months), who were diagnosed and treated for advanced intraocular retinoblastoma between June 2012 and February 2017, 3 patients [ages and sexes not stated] were described who developed myelosuppression, vomiting, hair loss or pancytopenia during treatment with melphalan and an unspecified antineoplastic for retinoblastoma [dosages and durations of treatment to reactions onsets not stated]. …

Chen Q, et al. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age. BMC Cancer 19: No. 1, Part 693, 15 Jul 2019. Available from: URL: http://doi.org/10.1186/s12885-019-5844-5 - China

Title: Antineoplastics
Various toxicities: 3 case reports
Publication date: 01-09-2019
Publisher: Springer International Publishing
Keywords: Retinoblastoma
Vomiting
Retinoblastoma
Published in: Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-67073-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics

Various toxicities: 3 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Bosutinib

Trametinib

Immunodepression/voriconazole

Hydroxycarbamide

Posaconazole

Anaesthetics/rocuronium-bromide